Cagrilintide
Sourcing GuideSourcing Cagrilintide from research-grade vendors requires the QC framework that governs any peptide procurement: certificate of analysis review, lot-specific verification, third-party laboratory issuance, and — critically — endotoxin testing for injectable material. A long-acting amylin analogue paired with semaglutide for weight loss results that exceed either drug alone. The three-tier vendor market (pharmaceutical-grade compounded, reputable research-grade, grey-market) is described below.
Key Takeaways
Procurement lens: Cagrilintide sourcing requires lot-specific COA, HPLC purity ≥98%, mass spec confirmation matching ~4400 Da. Mechanism: Selectively activates the amylin receptor (calcitonin receptor + RAMP1/3 complex). Storage: lyophilised at -20°C for 18-24 months; reconstituted at 4°C for 14-28 days. Vendor tier: pharmaceutical-grade compounded > reputable research-grade > grey-market (3-5x cost differential; quality differential substantially larger). Sourcing-validated stack partners: BPC-157, TB-500, GHK-Cu.
Selectively activates the amylin receptor (calcitonin receptor + RAMP1/3 complex). Slows gastric emptying, suppresses postprandial glucagon, and acts centrally in the area postrema to suppress appetite. The C16 fatty-acid sidechain enables albumin binding and once-weekly dosing. Quality control discipline for Cagrilintide starts with mechanism understanding: which assays detect counterfeits, which impurities matter for the intended use, and which storage conditions preserve activity. The subsections work through HPLC purity, COA evaluation, reconstitution protocol, and vendor selection.
Reconstitution and storage protocols
Cagrilintide is typically supplied lyophilised in glass vials for reconstitution with bacteriostatic water. Standard reconstitution: dissolve at 1–2 mg/mL, store reconstituted material at 4°C, and use within 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Lyophilised storage at −20°C extends shelf life to 18–24 months for most peptides in this class.
Vendor tier comparison and price discipline
Three vendor tiers operate in the Cagrilintide market: pharmaceutical-grade compounded prescription (physician-supervised, full COA, ICP-MS where relevant, highest cost), reputable research-chemical vendors (full COA, lot-specific, mid-tier cost), and grey-market unverified sources (template or absent COA, unverifiable supply chain, lowest cost). The price differential between tiers is roughly 3–5x; the quality differential is substantially larger and concentrated in the bottom tier.
HPLC purity and analytical identity
Minimum acceptable HPLC purity for Cagrilintide is ≥98% in research-grade material. Mass spec confirmation should show the characteristic m/z of ~4400 (M+H)+. Contaminant peaks above 1% in the HPLC trace warrant quantification on the COA and — ideally — structural identification of the major impurities.
Pharmaceutical-grade compounded Cagrilintide is the lowest-risk sourcing path for gmp vs research grade use where the route permits, particularly for users with clinical supervision. Research-grade material from accredited vendors is the practical alternative; grey-market sourcing is not appropriate for this application.
Sourcing Cagrilintide for bac water sourcing use requires the same QC discipline as any peptide procurement: lot-specific COA, HPLC purity ≥98%, mass spec confirmation, endotoxin testing for injectable routes. Application-specific use does not relax the sourcing standard.
For users targeting hplc purity, the sourcing question is whether the chosen vendor consistently delivers analytical-spec material across lots. Repeated re-orders from the same vendor with mid-cycle COA spot-checks is the procurement pattern that catches lot drift before it affects results.
Pharmaceutical-grade compounded Cagrilintide is the lowest-risk sourcing path for coa review use where the route permits, particularly for users with clinical supervision. Research-grade material from accredited vendors is the practical alternative; grey-market sourcing is not appropriate for this application.
| Goal | Route | Dose | Cycle |
|---|---|---|---|
| Standard protocol | SubQ | 1.2-2.4 mg | 8–12 weeks on / 4 weeks off |
| Conservative starter | SubQ | 1.2-2.4 mg | 4–6 weeks initial cycle |
| Sourcing Guide focus | SubQ | 1.2-2.4 mg | 1x weekly SubQ |
| Maintenance phase | SubQ | 1.2-2.4 mg | Ongoing with periodic pauses |
Dose timing for Cagrilintide is less time-sensitive given the longer half-life. Consistency through the cycle is more important than the precise clock time of individual doses.
Cagrilintide stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from experienced peptide buyers.
- Cagrilintide + BPC-157: Upregulates VEGFR2 to promote angiogenesis and activates the FAK-paxillin pathway for accelerated tissue repair. Pairs naturally with Cagrilintide's mechanism in sourcing / quality / procurement protocols.
- Cagrilintide + TB-500: Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. Pairs naturally with Cagrilintide's mechanism in sourcing / quality / procurement protocols.
- Cagrilintide + GHK-Cu: GHK chelates copper(II) and acts as a transcriptional modulator: published microarray data show it influences over 4,000 human genes including resetting expression patterns toward younger cellular phenotypes. Pairs naturally with Cagrilintide's mechanism in sourcing / quality / procurement protocols.
- Cagrilintide + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with Cagrilintide's mechanism in sourcing / quality / procurement protocols.
Gastrointestinal events most common (nausea, vomiting), generally lower than GLP-1 mono-therapy. Pancreatitis caution; avoid in pregnancy.
Lens-specific safety considerations for sourcing / quality / procurement use of Cagrilintide: Gastrointestinal events most common (nausea, vomiting), generally lower than GLP-1 mono-therapy. Pancreatitis caution; avoid in pregnancy. Additional sourcing / quality / procurement monitoring at baseline and 6–8 week follow-up is appropriate.
| Compound | Profile | Onset | Best For |
|---|---|---|---|
| Cagrilintide | Long-acting amylin analogue | ~7 days | Sourcing Guide |
| BPC-157 | Stable gastric pentadecapeptide | ~4 hr (oral) | Accelerated tendon, ligament, and gut tissue repair via VEGFR2-driven angiogenesis and FAK-paxillin signalling |
| TB-500 | Synthetic thymosin β4 fragment | ~2-3 days | A 17-amino-acid synthetic fragment of thymosin β4 with actin-sequestering activity — drives cell migration, tissue repair, and broad regenerative effects |
| GHK-Cu | Tripeptide-copper complex | ~30 min plasma | A naturally occurring tripeptide-copper complex that declines with age and is studied for its broad effects on wound healing, skin remodelling, and gene expression |
| Ipamorelin | Selective GHRP / ghrelin mimetic | ~2 hr | The most selective ghrelin-receptor agonist among the GHRPs — stimulates GH release with minimal effect on cortisol, prolactin, or appetite |
Lot variability across orders?
Vendor red flags?
Pharmaceutical-grade versus research-grade?
Storage protocol?
What is the mechanism of action of Cagrilintide?
What is the regulatory status of Cagrilintide?
Start a Cagrilintide Protocol
Alukard provides GMP-certified physician-supervised sourcing with GMP-certified Cagrilintide and Pharmaceutical-grade compounds with full COA documentation.
Get ProtocolQuick Facts
- Molecular weight
- ~4400 Da
- Sequence length
- 37 aa
- Half-life
- ~7 days
- WADA
- Not on prohibited list
- FDA
- Investigational (Phase III combined with semaglutide as CagriSema)
- Research
- Phase III trials underway
Stack Partners
All sourcing / quality / procurement applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for Cagrilintide unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.
Start Your Sourcing / Quality / Procurement Protocol for Cagrilintide
Alukard provides GMP-certified physician-supervised sourcing with Pharmaceutical-grade compounds with full COA documentation.
HIPAA Compliant · GMP Certified · Physician Supervised